Comirnaty Authorized to Prevent COVID-19 in Children 5-11 Years Old
October 29, 2021CDC May Expand Hepatitis B Vaccination Recommendations
November 3, 2021November 1, 2021 – ANI Pharmaceuticals has announced U.S. FDA approval of the company's Purified CortrophinTM Gel (repository corticotropin injection). The product is indicated to treat certain rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, proteinuria, and acute exacerbations of multiple sclerosis.
- Recommended dosing is based on factors that include the indication, severity of disease, and general medical condition of the patient. Purified Cortrophin Gel is administered either subcutaneously or intramuscularly and can be self-administered or administered by a caregiver.
- ANI Pharmaceuticals plans to launch the drug during the first quarter of 2022. Pricing is not yet available.